XXIIConsumer Defensive · TobaccoXXII Stock Forecast: 22nd Century Group, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 12 of 100 as at 1 Aug 2026 — in the weakest quartile.
XXII stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores 22nd Century Group, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (99): Smaller than most of the companies we track.
Value (0): The shares cost a lot relative to the profits and assets behind them.
The rank is the raw material. Whether the rules would actually own 22nd Century Group, Inc. — and when they’d sell — is the membership.
XXII stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on XXII, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 23 Aug 2023 | Roth MKM | Reiterates | Buy | $5.00 |
| 17 Aug 2023 | Alliance Global Partners | Downgrade | Neutral | — |
| 15 Aug 2023 | Dawson James | Maintains | Buy | — |
| 15 Aug 2023 | TD Cowen | Downgrade | Market Perform | — |
| 3 July 2023 | Dawson James | Maintains | Buy | — |
| 9 Nov 2022 | Alliance Global Partners | Maintains | Buy | $5.00 → $4.00 |
| 21 July 2022 | Alliance Global Partners | Initiates | Buy | $5.00 |
| 15 June 2022 | Craig-Hallum | Initiates | Buy | — |
| 8 Mar 2022 | Roth Capital | Initiates | Buy | — |
| 4 Mar 2022 | Dawson James | Maintains | Buy | — |
| 24 Feb 2022 | Dawson James | Maintains | Buy | — |
| 16 Feb 2022 | Dawson James | Maintains | Buy | — |
| 24 Jan 2022 | Dawson James | Maintains | Buy | — |
| 6 Jan 2022 | Dawson James | Maintains | Buy | — |
| 23 July 2021 | Cowen & Co. | Initiates | Outperform | — |
| 26 Jan 2018 | Chardan Capital | Maintains | Buy | $12 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
XXII analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
22nd Century Group, Inc. (XXII) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 0.0×
- Price / sales
- 0.2×
- Price / book
- 0.1×
- EV / EBITDA
- 0.7×
Cheaper than 75% of US stocks
Cheaper than 92% of US stocks
Cheaper than 90% of US stocks
Cheaper than 59% of US stocks
- Revenue growth (YoY)
- −43.3%
- Earnings growth (YoY)
- −43.3%
- Gross margin
- −49.3%
- Operating margin
- −235.8%
- Net margin
- −65.8%
Higher than 6% of US stocks
Higher than 12% of US stocks
Higher than 3% of US stocks
Higher than 10% of US stocks
Higher than 8% of US stocks
- Return on equity
- −103.5%
- Return on assets
- −28.3%
- Dividend yield
- —
Higher than 12% of US stocks
Higher than 15% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
XXII vs competitors
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| XXII22nd Century Group, Inc. | $1.4M | 12 |
| GNLNGreenlane Holdings, Inc. | $1.2M | 10 |
| RKDAArcadia Biosciences, Inc.* | $1.4M | 19 |
| EDBLEdible Garden AG, Inc.* | $1.5M | 9 |
| IBGInnovation Beverage Group Ltd.* | $1.6M | 3 |
| MSSMaison Solutions, Inc.* | $1.2M | 30 |
| RYMRYTHM, Inc. | $38.9M | 19 |
* Nearest Consumer Defensive names by size — few tobacco companies of this scale trade in the US universe.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. XXII appears on the weeks it earns a place.
Frequently asked questions about XXII stock
How does Ticker Nerd's model rank XXII?
As at 1 Aug 2026, 22nd Century Group, Inc. ranks 12 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (99 of 100).
What is the XXII stock forecast for 2030?
No analyst covering 22nd Century Group, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for XXII are extrapolating price history, which says nothing about the business.
How has XXII stock performed over the past year?
22nd Century Group, Inc. returned -99.4% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does 22nd Century Group, Inc. do?
22nd Century Group Inc. is a biotechnology company specializing in the genetic engineering of tobacco and cannabis plants.
About 22nd Century Group, Inc.
22nd Century Group Inc. is a biotechnology company specializing in the genetic engineering of tobacco and cannabis plants. The company's primary function is to develop plant varieties with modified levels of nicotine and cannabinoid profiles, aiming to meet evolving consumer and regulatory demands. A key feature of 22nd Century Group Inc. is its focus on creating low-nicotine tobacco products and hemp/cannabis plants with specific cannabinoid contents. These innovations have significant implications for the agricultural biotechnology sector and public health policy discussions regarding tobacco harm reduction. By leveraging its proprietary genetic technologies and collaborations, the company positions itself as a leader in altering plant alkaloid content to enhance product offerings and create potentially safer tobacco alternatives. Headquartered in the United States, 22nd Century Group Inc. plays a strategic role in both the tobacco and cannabis industries, addressing the growing need for reduced-risk products while exploring the vast potential of cannabinoid applications. Its contributions reflect broader trends in biotechnology, agriculture, and consumer health advocacy, making it a company of interest in these intersecting fields.
CEO Mr. Lawrence D. Firestone · 32 employees · United States · https://www.xxiicentury.com